B-Thalessemia Hello, Mr. And Mrs. Jones. You came to us because you each have relatives with B-thalessemia. You wanted to know what the chances were that you would have children with this disease. The only way a baby can be born with B-thalessemia is if both parents carry the gene for it. At conception, each child receives one set of genes from each parent. Because each of you received one gene for B-thalessemia,

The use of hydroxyurea and postoperative heparin prophylaxes were also included in the recorded observations made by the researchers. Standard statistical techniques including regression analysis were used to determine the levels of correlation that existed between transfusion therapy, pharmaceutical use, and complications. Materials As this was a retrospective study that did not involve any direct experimentation or even direct observation, the materials used were rather minimal compared to many other clinical

Another symptom that is often found is a yellowing of skin and eyes; this is a sign of jaundice due to the breakdown of red blood cells. Another sign is that children may show delayed growth and development. (Genetic Disease Profile: Sickle Cell Anemia) One of the aspects that problematizes this disease are the complications that can arise as a result of the lowering of body defenses and the increased

Essay Topic Examples 1. The Genetic and Molecular Basis of Sickle Cell Anemia:     Explore the hereditary factors of sickle cell anemia, including the mutation in the HBB gene that leads to the production of abnormal hemoglobin. Discuss the implications of this mutation on the red blood cells and the resultant pathophysiology. 2. Sickle Cell Anemia and Its Global Health Impact:     Analyze the prevalence of sickle cell anemia in various regions around the world and

The world heath today is experiencing of cancer as a very dangerous disease. This illness often affects those individuals who are 65 years of age and above. Other predisposing factors are being an African -American and being from a family whose members have been suffered this kind of illness. Cancer can start from any part of the body as it starts it growth in cells. This can spread to other

Chronic Myelogenous Leukemia (CML): Treatment Options Patients suffering from chronic myelogenous leukemia (CML) experience recurrent infections, anemia, and thrombocytopenia, signs and symptoms often manageable without professional help. Accordingly, patients often failed to seek medical care until late in the disease course and would have had a poor prognosis in the 20th century. Today, a number of effective treatments are available, including the highly effective kinase inhibitor imatinib. Kinase inhibitors suppress the